ACRP CP Test 1 Questions with Verified
Correct Answers
1571
IND application; Permit to do research on humans for the first time; has background info; and
rationale; updated annually
1572
Investigator statement; commitment, done nationally and internationally by sponsors
intending to hava marketing aproval for IP
IB
Clinical and non-clinical data on the investigational product that is relevant to the study in
human subjects; supplied prior to regulatory approval
Study type - Open Label
everyone knows the treatment
Study type - Single blind
one party knows Tx, usually the patient does not know but the monitoring team does
Study type - Double Blind
2 or more people are blinded, usually the patient and monitoring tram do not know which
drug is given.
A 3rd party unblinded pharmacist is used and an unblinded CRA is needed
Study Type - Double dummy
Correct Answers
1571
IND application; Permit to do research on humans for the first time; has background info; and
rationale; updated annually
1572
Investigator statement; commitment, done nationally and internationally by sponsors
intending to hava marketing aproval for IP
IB
Clinical and non-clinical data on the investigational product that is relevant to the study in
human subjects; supplied prior to regulatory approval
Study type - Open Label
everyone knows the treatment
Study type - Single blind
one party knows Tx, usually the patient does not know but the monitoring team does
Study type - Double Blind
2 or more people are blinded, usually the patient and monitoring tram do not know which
drug is given.
A 3rd party unblinded pharmacist is used and an unblinded CRA is needed
Study Type - Double dummy
